Cargando…

Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?

For many years, conventional oncologic treatments such as surgery, chemotherapy, and radiotherapy (RT) have dominated the field of non-small-cell lung cancer (NSCLC). The recent introduction of immunotherapy (IT) in clinical practice, especially strategies targeting negative regulators of the immune...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spaas, Mathieu, Lievens, Yolande
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853895/ https://www.ncbi.nlm.nih.gov/pubmed/31788476 http://dx.doi.org/10.3389/fmed.2019.00244

Ejemplares similares

Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
por: Sundahl, Nora, et al.
Publicado: (2021)

Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer
por: Abe, Takanori, et al.
Publicado: (2021)

New challenges in the combination of radiotherapy and immunotherapy in non-small cell lung cancer
por: Luna, Javier, et al.
Publicado: (2021)

Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer
por: Jie, Chen, et al.
Publicado: (2023)

Combined treatment of non‐small cell lung cancer using radiotherapy and immunotherapy: challenges and updates
por: Shang, Shijie, et al.
Publicado: (2021)

Combination of immunotherapy and radiotherapy in the treatment of brain metastases from non-small cell lung cancer
por: Suwinski, Rafal
Publicado: (2021)

Combining stereotactic body radiotherapy with immunotherapy in stage IV non-small cell lung cancer
por: Liu, Xiaoli, et al.
Publicado: (2023)

Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy: the Lung PLUS study
por: van der Weijst, Lotte, et al.
Publicado: (2023)

The Combination of Radiotherapy With Immunotherapy and Potential Predictive Biomarkers for Treatment of Non-Small Cell Lung Cancer Patients
por: Meng, Lu, et al.
Publicado: (2021)

EGFR Mutation Positive Stage IV Non-Small-Cell Lung Cancer: Treatment Beyond Progression
por: Van Assche, Katrijn, et al.
Publicado: (2014)

Effect of acute aerobic exercise before immunotherapy and chemotherapy infusion in patients with metastatic non-small-cell lung cancer: protocol for the ERICA feasibility trial
por: Gouez, Manon, et al.
Publicado: (2022)

A narrative review of combined stereotactic ablative radiotherapy and immunotherapy in metastatic non-small cell lung cancer
por: Akanda, Zarique Z., et al.
Publicado: (2021)

Research Progress on Radiotherapy Combined with Immunotherapy for Associated Pneumonitis During Treatment of Non-Small Cell Lung Cancer
por: Zhang, Anqi, et al.
Publicado: (2022)

Is immunotherapy at reduced dose and radiotherapy for older patients with locally advanced non-small lung cancer feasible?—a narrative review by the international geriatric radiotherapy group
por: Vinh-Hung, Vincent, et al.
Publicado: (2022)

Provision and use of radiotherapy in Europe
por: Lievens, Yolande, et al.
Publicado: (2020)

Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review
por: Van Der Weijst, Lotte, et al.
Publicado: (2019)

Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
por: Zhang, Qun, et al.
Publicado: (2022)

Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy
por: Jiang, Mingxia, et al.
Publicado: (2021)

Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer
por: Adderley, H., et al.
Publicado: (2020)

Feasibility of stereotactic body radiotherapy for locally-advanced non-small cell lung cancer
por: Woodford, Katrina, et al.
Publicado: (2017)

Combining immunotherapy and radiotherapy in lung cancer: a promising future?
por: Zhou, Jieling, et al.
Publicado: (2020)

Immunotherapy in Advanced Non-small Cell Lung Cancer Patients: Ushering Chemotherapy Through the Checkpoint Inhibitors?
por: Kanwal, Bushra, et al.
Publicado: (2018)

Effective Combinations of Immunotherapy and Radiotherapy for Cancer Treatment
por: Yu, Siting, et al.
Publicado: (2022)

Retracted: Analysis of Immunotherapy Combined with Radiotherapy in Patients with Brain Metastasis of Driver Gene-Negative Non-Small-Cell Lung Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Radiotherapy and Immunotherapy in Lung Cancer
por: Hsieh, Kristin, et al.
Publicado: (2023)

Real-World Analysis of the Impact of Radiotherapy on Immunotherapy Efficacy in Non-Small Cell Lung Cancer
por: Onn, Amir, et al.
Publicado: (2021)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
por: Lazzari, Chiara, et al.
Publicado: (2018)

Synergistic effect of immunotherapy and radiotherapy in non-small cell lung cancer: current clinical trials and prospective challenges
por: Yang, Hui, et al.
Publicado: (2019)

Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancer
por: Zhang, Luping, et al.
Publicado: (2016)

Radiotherapy for extensive-stage small-cell lung cancer in the immunotherapy era
por: Li, Huanhuan, et al.
Publicado: (2023)

Combination strategies of immunotherapy in non-small cell lung cancer: facts and challenges
por: Li, Chu-Ling, et al.
Publicado: (2021)

Combinations of radiotherapy with immunotherapy in cervical cancer
por: Yang, Xiaojing, et al.
Publicado: (2022)

Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge—a narrative review
por: Xia, Wu-Yan, et al.
Publicado: (2020)

Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer
por: Chodavadia, Parth A., et al.
Publicado: (2021)

Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer
por: Ye, Wei, et al.
Publicado: (2022)

Liquid Biopsy in Non-Small Cell Lung Cancer
por: Molina-Vila, Miguel A., et al.
Publicado: (2016)

Immunotherapy for Non-Small Cell Lung Cancer
por: Yoon, Sung Ho
Publicado: (2014)

Feasibility of sleeve lobectomy after neo-adjuvant chemo-immunotherapy in non-small cell lung cancer
por: Chen, Yulong, et al.
Publicado: (2020)

Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer
por: Parekh, Jay, et al.
Publicado: (2023)

The Combined Clinical Efficacy and Safety Analysis of Adoptive Immunotherapy with Radiotherapy and Chemotherapy in Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis
por: Fan, Zhiming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ka5805810pd87089qt4524sek8